The benefit of implantable cardioverter-defibrillator (ICD) therapy depends upon appropriate
evaluation of a persisting risk of sudden death and estimation of the patient's overall …

Dilated cardiomyopathy (DCM) is an important cause of sudden cardiac death (SCD) and
heart failure (HF) and is the leading indication for cardiac transplantation in children and …

Diabetes increases oxidant stress and doubles the risk of dying after myocardial infarction,
but the mechanisms underlying increased mortality are unknown. Mice with streptozotocin …

Objectives: The aim of this study was to describe usage of the wearable cardioverter-
defibrillator (WCD) during mandated waiting periods following myocardial infarction (MI) for …

Background—Implantation of implantable cardioverter defibrillator for prevention of sudden
cardiac death is deferred for 90 days after coronary revascularization, but mortality may be …

Objectives: This study sought to hypothesize that global longitudinal strain (GLS) as a
measure of infarct size, and mechanical dispersion (MD) as a measure of myocardial …

The connection between the heart and the brain has long been anecdotally recognized but
has systematically been studied only relatively recently. Cardiac arrhythmias, especially …

Aims It remains unclear whether primary prophylactic implantable cardioverter-defibrillator
(ICD) therapy is cost-effective compared with a 'no ICD strategy'in the European health care …

Identification of individuals at risk for sudden cardiac death (SCD), the main cause of adult
mortality in developed countries, remains a major challenge. The main contemporary …

Since its introduction> 3 decades ago, the implantable cardioverter-defibrillator (ICD) has
been used extensively to enhance the survival of patients at high risk for sudden cardiac …